Pernix Therapeutics announced that Omeclamox-Pak is now available for the treatment of Helicobacter pylori (H. pylori) infection and duodenal ulcer disease (active or one-year history) to eradicate H. pylori in adult patients.

Omeclamox-Pak is a ten-day, triple combination oral therapy comprised of omeprazole delayed-release capsules (20mg), clarithromycin tablets (500mg) and amoxicillin capsules (500mg).

Omeprazole, a proton pump inhibitor, works by decreasing the amount of acid the stomach produces. Clarithromycin and amoxicillin are antibacterial drugs, which inhibit the growth of bacteria allowing the stomach lining to heal.

Each Omeclamox-Pak box contains ten individual daily dose cards, each comprised of one omeprazole delayed-release capsule, one clarithromycin tablet, and two amoxicillin capsules.

For more information call (800) 793-2145 or visit